Novel coordinating motifs for lanthanide(III) ions based on 5-(2-pyridyl)tetrazole and 5-(2-pyridyl-1-oxide)tetrazole. Potential new contrast agents† Antonio Facchetti,*a Alessandro Abbotto,b Luca Beverina,b Silvia Bradamante,c Palma Mariani,d Charlotte L. Stern,a Tobin J. Marks,a Alberto Vaccad and Giorgio A. Pagani*b a Department of Chemistry, Northwestern University, 2145 Sheridan Road, 60208, Evanston, IL, USA b Department of Materials Science, University of Milano-Bicocca, Via Cozzi 53, I-20125, Milano, Italy c CNR-Institute of Molecular Science and Technologies, Via Golgi 19, I-20133, Milano, Italy d Department of Chemistry, University of Florence, Via della Lastruccia 3, I 50019, Sesto Fiorentino, Italy Received (in Cambridge, UK) 9th February 2004, Accepted 2nd June 2004 First published as an Advance Article on the web 30th June 2004 Water-soluble and neutral Ln(III) and Zn (II) complexes of
employing m-chloroperbenzoic acid in MeOH. This result is
pyridine- and (pyridine-1-oxide)tetrazole have been synthesized
remarkable considering the large number of azine nitrogens present
and the Gd derivatives have great potential as high-relaxivity
in 1 and 3. Indeed, other oxidizing agents such as H2O2 and low-osmolarity MRI contrast agents.
CH3CO3H afford inseparable mixture of products. The protonation constant of 1 (pKa = 4.11) and 2 (pKa = 3.55) were obtained via
The emergence of magnetic resonance imaging (MRI) techniques
potentiometric titration. The pKa values are lower than in tetrazole
for medical diagnosis has been accompanied by an intensive growth
due to conjugation with the electron-poor pyridine ring. To fully
of interest in the study of paramagnetic metal complexes as contrast
explore the ligand capacities of both –NNC–C–N2– and O2–
agents (CAs) designed to enhance tissue differentiation.1,2 The
N+NC–C–N2– moieties present in this new class of ligands, anions
majority of the approved CAs are Gd(III) chelates, the efficiency of
12 and 22 were reacted with both a transition metal ion [Zn(II), to
which is given by the proton relaxivity, r1, described as the proton
allow chelate 1H NMR analysis] and a set of lanthanide [Gd(III),
relaxation rate enhancement in the presence of the CA compared to
Eu(III), and Dy(III)] ions, whereas ligands 32 and 42 were
a diamagnetic environment. Currently, all Gd(III)-based chelates
investigated targeting both Zn(II) and Gd(III) ions.
approved for use in MRI are nine-coordinate complexes in which a
The synthesis of neutral chelates 1–4 was planned depending on
ligand occupies eight binding sites at the metal center and the ninth
their expected solubility properties. Poorly or relatively soluble
coordination site is occupied by one water molecule. Most of the
chelates were prepared by reacting LH with the stoichiometric
investigated CAs are derivatives of a limited number of coordinat-
amount of K2CO3 in H2O (Scheme 2A). The corresponding anion
ing core structures, such as those of DTPA (diethelenetriamine-
L2 was then reacted with concentrated aqueous solutions of the
N,N,NA,NB,NB-pentaacetic acid) and DOTA (1,4,7,10-tetraazacy-
corresponding metal salts (acetate or chloride) and the resulting
clododecane-N,NA,NB,NÚ-tetraacetic acid) which have relaxivity
complexes isolated by filtration. For highly soluble Gd chelates, the
values of ~ 4–5 mM21s21.3 Incorporation/functionalization of
ligand anion was prepared by reacting LH with BaCO3 (Scheme
these ligand motifs into polymeric, dendrimeric, and protein
2B). A solution of Gd2(SO4)4 was then added to the barium salt, and
structures increases the rotational correlation time and results in
the insoluble BaSO4 filtered off. Evaporation of water afforded the
dramatically improved r1 values.3,4 However, the maximum values
chelate. All the chelates (Table S1, Supporting Information†) were
are still about half of the possible theoretical limit ( ~ 100
purified by crystallization from either H2O or H2O–MeOH.
Single crystals of Gd(12)3, Gd(22)3, and Zn(22)2 were obtained
From this intense research effort, all heteroaromatic-based
either by cooling of a saturated solution or slow evaporation of an
ligands are practically absent. This is surprising considering the
aqueous solution of the complex.§ The Gd(III) ion in Gd(12)3 and
rich chemistry, stability, and good coordinating properties of many
Gd(22)3 (Fig. 1) is nona- and octacoordinate by three bidentate
heterocycles.5 We describe here a new family of ligands (LH = 1–4) based on the pyridine/pyridine-N-oxide–tetrazole skeleton. Ligands 3 and 4 bearing hydrophilic chains were envisioned to improve solubility in water. Thanks to the acidity of tetrazole (pKa
= 4.89 in H2O)5 all these systems form stable anions (L2) at
physiological pH range, which act as efficient ligands to transition[Zn(II)] and lanthanide [Gd (III), Eu(III), Dy(III)] metal ions. Scheme 1 Synthetic routes to ligands 1–4.
Compound 16 and new ligands 2–4 were prepared according to
Scheme 1.‡ The tetrazole ring in 1 and 3 was synthesized by reaction of the corresponding cyanopyridine with HN3 (NaN3 + NH4Cl) in DMF at 130 °C. Regioselective oxidation of the pyridine nitrogen of 1 and 3 to afford 2 and 4, respectively was achieved
† Electronic supplementary information (ESI) available: chelate analytical
data, crystal structure of Zn(22)2, potentiometric titrations, and relaxivity
plots. See http://www.rsc.org/suppdata/cc/b4/b401919a/
Scheme 2 Synthetic routes to the neutral chelates. C h e m . C o m m u n . , 2 0 0 4 , 1 7 7 0 – 1 7 7 1
T h i s j o u r n a l i s T h e R o y a l S o c i e t y o f C h e m i s t r y 2 0 0 4
mL) was reacted at 130 °C for 2–4 h. After cooling, the inorganic salts were discarded by filtration and the solvent removed under reduced pressure. The residue was taken up with dilute HCl (0.1 M, 20 mL) and the formed solid collected and recrystallized from H2O. 1 (78%): mp 213 °C; 1H NMR (300 MHz, DMSO-d6): d 8.79 (dd, J = 5.0, 1.7, H-6); 8.22 (d, J = 8.0, H-3); 8.08 (td, H-4); 7.63 (dd, J = 8.0, H-5). 3 (76%): mp > 240 °C; 1H NMR (300 MHz, DMSO-d6): d 9.18 (d, J = 2.0, H-2); 8.47 (dd, J = 8.3, 2.0, H-4); 8.44 (d, J = 8.0, –CONH–); 8.32 (d, J = 8.0, H-5); 4.70 (s, OH); 4.01 (dtt, J = 8.0, 5.8, 5.8, CH); 3.60–3.48 (m, CH2). Ligands 2 and 4. A mixture of parent pyridyltetrazole (6.8 mmol) and m-chloroperbenzoic acid (11.6 mmol) in MeOH (200 mL) was reacted overnight at room temperature without Fig. 1 Crystal structure of Gd(12)3 and Gd(22)3.
stirring. 2 (66%) was isolated by filtration and recrystallized from H2O. mp
> 240 °C; 1H NMR (300 MHz, DMSO-d6): d 8.56 (d, J = 6.4, H-6); 8.41
(dd, J = 7.8, 2.1, H-3); 7.66 (td, H-4); 7.63 (dd, J = 7.7, H-5). 4 (80%) was
ligands and three/two H2O molecules, respectively. The different
isolated by evaporating the solvent and, after washing the solid with CH2Cl2
coordination number probably reflects the dissimilar steric require-
(300 mL), recrystallized from EtOH/H2O. mp > 240 °C; 1H NMR (300
ments3 of a five- versus a six-membered chelation motif for 1 and
MHz, DMSO-d6): d 8.97 (s, H-2); 9.49 (d, J = 8.5, H-4); 8.53 (d, J = 8.5,
2, respectively. Interestingly, three/five additional H2O molecules
– CONH–); 7.92 (d, J = 8.5, H-5); 4.70 (s, OH); 4.01 (m, CH); 3.60–3.40
are present in the second coordination sphere, suggesting large
relaxivity values. The geometry of Zn(22)
§ Crystal Structure. All measurements were made on a Bruker SMART
octahedral with two equatorial ligands and two H
CCD diffractometer with graphite monochromated MoKa (0.71073 Å)
radiation. The data were collected at a temperature of 153(2) K and thestructures were solved by direct methods and expanded using Fourier
Ligands 1–4 and the corresponding Gd(III) chelates are highly
techniques using SHELXTL. All non-hydrogen atoms were refined
soluble in H2O. Chelate solubility increases going from the
anisotropically. Hydrogen atoms were included in idealized positions and
unsubstituted 1 (2.1 g L21) and 2 (4.7 g L21)) to the hydroxyalkyl-
not refined. Intensities were corrected for absorption. Gd(12)3. Monoclinic,
substituted 3 (25.6 g L21) and 4 (21.2 g L21) systems. An P2(1)/n, Z = 4. Cell dimensions: a = 9.0273(9) Å; b = 17.714(3) Å; c =
additional requirement for practical application of Gd(III) com-
16.7480(19) Å; a = 90°; b = 99.819(9)°; g = 90.00°. V = 2639.0(6) Å3,
plexes is thermodynamic stability, to avoid toxicity of the metal.
rcalcd = 1.794 g cm23, total/independent reflections = 24502/6489, R(int)
Potentiometric data obtained by titration of a Gd:LH (LH = 1 and
= 0.0415, R = 0.0280. Zn(22)2. CCDC 232483.Monoclinic, C2/c, Z = 8. 2, Figs. S3 and S4†) mixture in the pH range of 2–5 (T = 298 K,
Cell dimensions: a = 31.01(2) Å; b = 8.561(4) Å; c = 7.546(3) Å; a =
I = 0.1 M) can be fitted assuming the stepwise addition of up to
90°; b = 100.65(5)°; g = 90°. V = 1968.8(18) Å3, rcalcd = 1.875 g cm23,total/independent reflections = 8819/2401, R(int) = 0.0564, R = 0.0469.
three L2 to the Gd ion,7 leading to a cumulative stability constant
(logb) values of 6.7(2) and 8.66(7) for Gd(12)
3. CCDC 232481. Monoclinic, P2(1)/n, Z = 4. Cell dimensions: a =
3 and Gd(22)3,
7.847(3) Å; b = 39.783(7) Å; c = 9.092(3) Å; a = 90°; b = 96.50(3)°; g
respectively. As expected, these values are lower than those of
= 90.00°. V = 2820.0(2) Å3, rcalcd = 1.780 g cm23, total/independent
approved CAs based on macrocycle octadentate ligands ( >
reflections = 18878/5168, R(int) = 0.0393, R = 0.0762. CCDC 232482.
See http://www.rsc.org/suppdata/cc/b4/b401919a/ for crystallographic data
1 is the key property of a potential contrast
agent. Measurements were performed at pH = 5.7–7.2 and r1values (mM21 s21) were obtained from the slope of a plot of 1/T
1 (a) The Chemistry of Contrast Agents in Medical Magnetic ResonanceImaging, eds. A. Merbach and E. Toth, John Wiley and Sons, New York,
3] (concentration range 0.2–1 mM, Fig. S5†) and were
2001; (b) S. Aime, M. Botta, M. Fasano and E. Terreno, Acc. Chem. Res.,
found to be: Gd(12)3 (9.98); Gd(22)3 (9.25); Gd(32)3 (10.79);
1999, 32, 941; (c) P. Caravan, J. J. Ellison, T. J. McMurry and R. B.
Gd(42)3 (17.72). These very high values cannot be explained solely
Lauffer, Chem. Rev., 1999, 99, 2293; (d) S. H. Koenig and R. D. Brown
on the basis of a large number of water molecules probably
III, Prog. NMR Spectrosc., 1990, 22, 487; (e) B. L. Engelstad and G. L.
coordinating the metal ion in aqueous solution. Rather, very fast
Wolf, in Magnetic Resonance Imaging, eds. D. D. Stark and W. G.
exchange between inner/outer sphere water molecules with the bulk
Bradley, Jr., The C. V. Mosby Company, St. Louis, 1988.
2 (a) L. Luttuada and G. Lux, Tetrahedron Lett., 2003, 44, 3893; (b) L.
2O might be involved, as suggested for complexes of heptadentate
Vander Elst, M. Port, I. Raynal, C. Simonot and R. N. Muller, Eur. J.
In summary, we described here new bidentate ligand motifs
Inorg. Chem., 2003, 2495; (c) K. Kimpe, T. N. Parac-Vogt, S. Laurent, C.
based solely on heteroaromatic units and leading to water-soluble
Pierart, L. Vander Elst, R. N. Muller and K. Binnemans, Eur. J. Inorg. Chem., 2003, 3021; (d) R. D. Bolskar, A. F. Benedetto, L. O. Husebo, R.
neutral chelates. The Gd(III) complexes exhibit a large number of
E. Price, E. F. Jackson, S. Wallace, L. J. Wilson and J. M. Alford, J. Am.
coordinated H2O molecules and Gd(42)3 exhibits the highest r1 Chem. Soc., 2003, 125, 5471; (e) M. K. Thompson, M. Botta, G. Nicolle,
values reported to date for a low molecular weight molecule.
L. Helm, S. Aime, A. E. Merbach and K. N. Raymond, J. Am. Chem. Soc.,
Thanks to the facile functionalization of the pyridine ring,
2003, 125, 14274; (f) A. Borel, L. Helm and A. E. Merbach, Chem. Eur.
incorporation of these chelating motifs into a single tripodal
J., 2001, 7, 600.
hexadentate structure should greatly improve stability (necessary
3 Contrast Agents I/Magnetic Resonance Imaging., Ed. W. Krause, Topics
for application) and retain the intrinsic high relaxivity. Starting
in Current Chemistry, Springer, Berlin, 2002, Vol 221.
4 (a) R. N. Muller, B. Raduchel, H. R. Maecke and A. E. Merbach, Eur. J.
incorporation into slower rotational motion substrates such as
Inorg. Chem., 1999, 1949; (b) É. Tóth, F. Connac, L. Helm, K. Adzamli and A. E. Merbach, J. Biol. Inorg. Chem., 1998, 3, 606; (c) S. Aime, M.
proteins, dendrimers, and polysaccharides,1,2 as demonstrated
Botta, S. G. Crich, G. Giovenzana, M. Sisti and E. Terreno, J. Biol. Inorg.
successfully for functionalized DTPA-protein bound (r1 ~ 50
Chem., 1997, 2, 470; (d) É. Tóth, D. Pubanz, S. Vauthey, L. Helm and A.
mM21s21)4a and DOTA-dendrimer (r1 ~ 15–19 mM21s21)
E. Merbach, Chem. Eur. J., 1996, 2, 1607; (e) V. S. Vexler, O. Clement,
systems.4d Efforts in this direction are in progress.
H. Schmitt-Willich and R. C. Brasch, J. Magn. Res. Imaging, 1994, 4,
This work was supported by grants MURST II (0103-97) and
5 A. R. Katritzky in, Handbook of Heterocyclic Chemistry, Pergamon
6 J. M. Mc Manus and R. M. Herbst, J. Org. Chem., 1959, 24, 1462. Notes and references
7 Potentiometric data were analysed using HYPERQUAD program . P.
Gans, A. Sabatini and A. Vacca, Talanta, 1996, 43, 1739. Synthetic details. Ligands 1 and 3. A mixture of parent cyanopyridine
8 Y. Bretonniere, M. Mazzanti, J. Pecaut, F. A. Dunand and A. E. Merbach,
(5.3 mmol), NaN3 (8.0 mmol), NH4Cl (8.0 mmol) in anhydrous DMF (27
C h e m . C o m m u n . , 2 0 0 4 , 1 7 7 0 – 1 7 7 1
SRI LANKA NAVY TENDER INVITATION headquarters Chaithiya Colombo 01 CMS/P/540/2012 31/08/2012 M/S ………………………………………………………………………………… QUOTATION FOR SUPPLY OF MEDICAL ITEMS Tenders are invited for the supply of items in the attached list. The tenders should be sent in duplicate in favor of Chairman, Tend
Dear Community Friend: Last year was economically difficult for so many people, and 2011 promises to bring more financial challenges. In response to even greater need, Abbott is increasing access to our HIV medications, Kaletra® (lopinavir/ritonavir) and Norvir® (ritonavir). Working with community leaders in the United States, Abbott is making some important changes and expanding several existi